![]() CAPHRA warns Philippines health controversy raises new questions over WHO and Bloomberg policy influenceBy: CAPHRA MANILA, Philippines - June 21, 2026 - PRLog -- The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) says fresh allegations involving senior Philippine health officials should trigger urgent scrutiny of how foreign-funded and internationally aligned interests influence domestic health policy.
Complaints reported this week allege that Health Secretary Teodoro Herbosa and other Department of Health officials were involved in the diversion of P145.9 million intended for domestic health services to support a World Health Organization Western Pacific regional initiative. According to the reported complaint, the funds were meant for domestic prevention and health promotion programs but were allegedly redirected to support a regional WHO-linked project spanning 37 countries and areas in the Western Pacific. Nancy Loucas, Executive Coordinator of CAPHRA, said the issue goes far beyond one dispute over funding. "This is about policy integrity, transparency, and sovereignty," CAPHRA noted that concerns about external influence over nicotine and tobacco policy in the Philippines are not new. In 2020, Philippine FDA officials acknowledged during congressional proceedings that the agency had received funding from The Union and the Bloomberg Initiative while developing regulations for e-cigarettes and heated tobacco products, prompting allegations of conflict of interest and calls for legislative inquiry. Clarisse Virgino of CAPHRA Philippines said the latest controversy feels uncomfortably familiar. "I was present during the earlier committee hearings when the Bloomberg-linked funding issue first raised serious questions about outside influence on Philippine nicotine policy," Virgino said. "What we are seeing now feels like history repeating itself — the same concerns about transparency, accountability, and whether foreign-backed agendas are being allowed to shape decisions that should be made in the interests of Filipinos." The group said that earlier controversy matters now because it shows a pattern of donor-linked policy pressure in an area where the Philippines should be making independent, evidence-based decisions. "When the same small policy ecosystem keeps appearing around opaque funding, anti-harm-reduction advocacy, and efforts to steer national regulation, governments have every reason to ask hard questions," Loucas said. "Filipinos deserve health policy made in the interests of Filipinos, not priorities imported through donor influence." CAPHRA is calling for full disclosure of all foreign-funded public health partnerships involving nicotine and tobacco regulation, publication of grant terms and technical assistance arrangements, and an independent review of how international agencies and private donors engage with domestic policymaking in the Philippines. The group said accountability, transparency, and local ownership are essential if public trust in health institutions is to be maintained. www.caphraorg.net End
|